← Back to Bafna Pharmaceuticals Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
BAFNAPHPharmaceuticals

Bafna Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹109.34
-4.38%
P/E Ratio34.53xIndustry: 31.77x
ROE7.69%Return on equity
ROCE8.34%Return on capital
Debt/Equity0.36Low debt
💎

Valuation & Profitability

P/E Ratio
34.53x
Industry Average P/E
31.77x
Dividend Yield
0.00%
Market Cap
₹364.97 (Cr)
Sales Growth 5Y
27.99%
Profit Growth 5Y
40.15%
EPS Growth 5Y
18.54%
OPM 5Y Avg
10.58%
📉

Price Returns

1 Month
+7.42%
3 Months
+47.14%
6 Months
+110.91%
1 Year
+92.87%
52W Low
₹71
Current
₹109
52W High
₹202
29% of 52-week range — Near lows
🔬

Technical Indicators

51RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
₹115
▼ Price below SMA 50 — Bearish
SMA 200
₹123
▼ Long-term downtrend
Volume Signal
362% of avg
Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Bafna Pharmaceuticals Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.